Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate Jonathan E. Blume, MD, Howard L. Stoll, MD, Richard T. Cheney, MD Journal of the American Academy of Dermatology Volume 54, Issue 5, Pages S229-S230 (May 2006) DOI: 10.1016/j.jaad.2005.11.1037 Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A, An erythematous, indurated plaque with moist, crusted nodules on the left distal portion of the forearm. B, Only a flat scar remains on the left forearm after two treatments of intralesional methotrexate. Journal of the American Academy of Dermatology 2006 54, S229-S230DOI: (10.1016/j.jaad.2005.11.1037) Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 A, A diffuse dermal infiltrate of atypical lymphoid cells. B, Chronic inflammation and fibroplasias with vascular proliferation. (A and B, Hematoxylin–eosin stain; original magnifications: A, ×40; B, ×20). Journal of the American Academy of Dermatology 2006 54, S229-S230DOI: (10.1016/j.jaad.2005.11.1037) Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions